A significant decrease in the mRNA levels of both cFLIP isoforms was observed in tumor cells treated with simvastatin at a concentration that caused a marked inhibition of CTGF gene expression (Figure 6E), a downstream target of the YAP/TAZ/TEAD transcriptional module. The gene discussed is CFLAR; the disease is neoplasm.